| 11/01/19 | 14:00:32 | 11 Jan 2019 | | Price Monitoring Extension | RNS |
| 11/01/19 | 11:05:38 | 11 Jan 2019 | | Second Price Monitoring Extn | RNS |
| 11/01/19 | 11:00:35 | 11 Jan 2019 | | Price Monitoring Extension | RNS |
| 11/01/19 | 09:05:27 | 11 Jan 2019 | | Second Price Monitoring Extn | RNS |
| 11/01/19 | 09:00:28 | 11 Jan 2019 | | Price Monitoring Extension | RNS |
| 10/01/19 | 16:41:13 | 10 Jan 2019 | | Second Price Monitoring Extn | RNS |
| 10/01/19 | 16:36:02 | 10 Jan 2019 | | Price Monitoring Extension | RNS |
| 10/01/19 | 16:01:02 | 10 Jan 2019 | | BREAKTHROUGH CANCER RESEARCH USING PARSORTIX | RNS |
| 09/01/19 | 07:00:02 | 9 Jan 2019 | | Notice of Results | RNS |
| 21/12/18 | 07:00:03 | 21 Dec 2018 | | Issue of LTIP Options and Share Options | RNS |
| 28/11/18 | 07:00:08 | 28 Nov 2018 | | LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR | RNS |
| 13/11/18 | 17:10:38 | 13 Nov 2018 | | Holding(s) in Company | RNS |
| 05/11/18 | 07:00:06 | 5 Nov 2018 | | Acquisition of outstanding shares | RNS |
| 02/11/18 | 14:00:35 | 2 Nov 2018 | | Price Monitoring Extension | RNS |
| 01/11/18 | 07:00:05 | 1 Nov 2018 | | Appointment of Dr Jan Groen as NED | RNS |
| 30/10/18 | 16:21:50 | 30 Oct 2018 | | Result of AGM | RNS |
| 29/10/18 | 07:00:07 | 29 Oct 2018 | | PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS | RNS |
| 25/10/18 | 08:00:05 | 25 Oct 2018 | | Good Progress with FDA Studies | RNS |
| 28/08/18 | 08:00:10 | 28 Aug 2018 | | Parsortix shows evidence of CTCs in glioblastoma | RNS |
| 24/07/18 | 18:42:32 | 24 Jul 2018 | | EIS/VCT Advance Assurance and Total Voting Rights | RNS |
| 18/07/18 | 11:34:23 | 18 Jul 2018 | | Result of General Meeting | RNS |
| 02/07/18 | 08:00:06 | 2 Jul 2018 | | Notice of Preliminary Results | RNS |
| 25/06/18 | 15:58:49 | 25 Jun 2018 | | Close of Accelerated Bookbuild | RNS |
| 04/06/18 | 08:00:09 | 4 Jun 2018 | | ENCOURAGING PROGRESS IN ANG-002 FDA CLINICAL STUDY | RNS |
| 14/05/18 | 08:00:11 | 14 May 2018 | | Leading cancer surgeon appointed | RNS |
| 03/05/18 | 08:00:04 | 3 May 2018 | | Angle & QIAGEN Poster | RNS |
| 19/04/18 | 08:00:06 | 19 Apr 2018 | | Parsortix in multiple presentations at AACR | RNS |
| 19/04/18 | 08:00:04 | 19 Apr 2018 | | Breakthrough Research with Parsortix | RNS |
| 05/04/18 | 08:00:03 | 5 Apr 2018 | | First patient enrolled in FDA study | RNS |
| 26/03/18 | 17:35:23 | 26 Mar 2018 | | Price Monitoring Extension | RNS |
| 26/03/18 | 08:00:03 | 26 Mar 2018 | | Research Update | RNS |
| 06/02/18 | 07:00:03 | 6 Feb 2018 | | ANGLE plc: RESEARCH GRANT FROM ABBOTT | RNS |
| 31/01/18 | 07:00:04 | 31 Jan 2018 | | Interim Results | RNS |
| 16/01/18 | 07:00:05 | 16 Jan 2018 | | WEBINAR:USING PARSORTIX TO TEST DRUGS ON LIVE CTCS | RNS |
| 10/01/18 | 10:16:42 | 10 Jan 2018 | | Notice of Results | RNS |
| 08/01/18 | 07:00:03 | 8 Jan 2018 | | ANGLE plc:Prostate cancer ARV7 treatment biomarker | RNS |
| 27/12/17 | 11:49:06 | 27 Dec 2017 | | Holding(s) in Company | RNS |
| 12/12/17 | 07:00:04 | 12 Dec 2017 | | Transfer of Lock-in Shares | RNS |
| 08/12/17 | 07:00:04 | 8 Dec 2017 | | PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER | RNS |
| 28/11/17 | 07:00:07 | 28 Nov 2017 | | Parsortix enables CTC molecular characterisation | RNS |
| 23/11/17 | 07:00:05 | 23 Nov 2017 | | PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER | RNS |
| 17/11/17 | 16:06:21 | 17 Nov 2017 | | Holding(s) in Company | RNS |
| 16/11/17 | 08:23:00 | 16 Nov 2017 | | Total Voting Rights and Covington Subscription | RNS |
| 06/11/17 | 07:00:04 | 6 Nov 2017 | | Holding(s) in Company | RNS |
| 06/11/17 | 07:00:04 | 6 Nov 2017 | | Holding(s) in Company | RNS |
| 06/11/17 | 07:00:04 | 6 Nov 2017 | | Holding(s) in Company | RNS |
| 02/11/17 | 10:04:07 | 2 Nov 2017 | | Holding(s) in Company | RNS |
| 01/11/17 | 08:12:01 | 1 Nov 2017 | | ANGLE: Completion of Fundraising and Acquisition | RNS |
| 31/10/17 | 14:18:10 | 31 Oct 2017 | | Result of AGM | RNS |
| 30/10/17 | 10:31:37 | 30 Oct 2017 | | Result of General Meeting | RNS |
